Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis. Armstrong AW, Blauvelt A, Lebwohl M, Asahina A, et al. Br J Dermatol 2025 May 14:ljaf171. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Armstrong AW, Blauvelt A, Lebwohl M, Asahina A, et al. Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis. Br J Dermatol 2025 May 14:ljaf171. doi: 10.1093.
PMID: 40365708